当前位置: X-MOL 学术Neuropsychol. Rehabilit. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
An exploration of aphasia therapy dosage in the first six months of stroke recovery
Neuropsychological Rehabilitation ( IF 2.7 ) Pub Date : 2020-06-14 , DOI: 10.1080/09602011.2020.1776135
Emily Brogan 1, 2 , Natalie Ciccone 1 , Erin Godecke 1, 2
Affiliation  

ABSTRACT

Aphasia research uses the length of time within rehabilitation sessions as the main measure of dosage. Few papers detail therapeutic ingredients or outline the number of times these were delivered over the treatment period. The present observational study identified therapeutic ingredients in the Very Early Rehabiltiation in SpEech (VERSE) trial and explored the dosage provided using a model of cumulative intervention intensity (CII). Therapists video recorded one therapy session per week and 53 (12%) randomly selected therapy videos were analysed. The videos were coded for number of error productions, self-corrections and type and frequency of therapist cueing. The Western Aphasia Battery Revised-Aphasia Quotient (WABR-AQ) was used for measuring patient outcome with total verbal utterances (p < 0.001) and cues used with success (p < 0.001) being independent positive predictors of WABR-AQ score at six months post stroke and hypothesized as key therapeutic ingredients. The CII was calculated by counting identified therapeutic ingredients and multiplying this by the number of sessions completed. Collectively, the key ingredients occurred on average 504 times per session and over 10,000 times per participant during the treatment period. This paper reports a novel approach for identifying key treatment ingredients and detailing the dosage delivered within an early aphasia rehabilitation trial.



中文翻译:

脑卒中恢复前6个月失语症治疗剂量探讨

摘要

失语症研究使用康复治疗中的时间长度作为剂量的主要衡量标准。很少有论文详细介绍治疗成分或概述治疗期间这些成分的使用次数。本观察性研究确定了语音早期康复 (VERSE) 试验中的治疗成分,并使用累积干预强度 (CII) 模型探索了提供的剂量。治疗师视频每周记录一次治疗,并分析了 53 个(12%)随机选择的治疗视频。这些视频被编码为错误产生的数量、自我纠正以及治疗师提示的类型和频率。Western Aphasia Battery Revised-Aphasia Quotient (WABR-AQ) 用于测量患者的总体言语表达结果(p < 0.001) 和成功使用的线索 ( p  < 0.001) 是中风后 6 个月 WABR-AQ 评分的独立阳性预测因子,并假设为关键治疗成分。CII 是通过计算确定的治疗成分并将其乘以完成的治疗次数来计算的。总的来说,在治疗期间,关键成分平均每次出现 504 次,每位参与者超过 10,000 次。本文报告了一种识别关键治疗成分并详细说明早期失语症康复试验中提供的剂量的新方法。

更新日期:2020-06-14
down
wechat
bug